Cost-Effectiveness of Multidisciplinary Management Program and Exercise Training Program in Heart Failure

      Heart failure causes significant health and financial burdens for patients and society. Multidisciplinary management program (MMP) and exercise training program (ETP) have been reported as cost-effective in improving health outcomes, yet no study has compared the 2 programs. We constructed a Markov model to simulate life year (LY) gained and total costs in usual care (UC), MMP, and ETP. The probability of transitions between states and healthcare costs were extracted from previous literature. We calculated the incremental cost-effectiveness ratio (ICER) over a 10-year horizon. Model robustness was assessed through 1-way and probabilistic sensitivity analyses. The expected LY for patients treated with UC, MMP, and ETP was 7.6, 8.2, and 8.4 years, respectively. From a societal perspective, the expected cost of MMP was $20,695, slightly higher than the cost of UC ($20,092). The cost of ETP was much higher ($48,378) because of its high implementation expense and the wage loss it incurred. The ICER of MMP versus UC was $976 per LY gained, and the ICER of ETP versus MMP was $165,702 per LY gained. The results indicated that, under current cost-effectiveness threshold, MMP is cost-effective compared with UC, and ETP is not cost-effective compared with MMP. However, ETP is cost-effective compared with MMP from a healthcare payer's perspective.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ho K.K.
        • Pinsky J.L.
        • Kannel W.B.
        • Levy D.
        The epidemiology of heart failure: the Framingham Study.
        J Am Coll Cardiol. 1993; 22: A6-A13
        • Mozaffarian D.
        • Benjamin E.J.
        • Go A.S.
        • Arnett D.K.
        • Blaha M.J.
        • Cushman M.
        • De Ferranti S.
        • Despres J.P.
        • Fullerton H.J.
        • Howard V.J.
        • Huffman M.D.
        Executive summary: heart disease and stroke statistics—2015 update.
        Circulation. 2015; 131: 434-441
        • MacIntyre K.
        • Capewell S.
        • Stewart S.
        • Chalmers J.W.T.
        • Boyd J.
        • Finlayson A.
        • Redpath A.
        • Pell J.P.
        • McMurray J.J.V.
        Evidence of improving prognosis in heart failure trends in case fatality in 66 547 patients hospitalized between 1986 and 1995.
        Circulation. 2000; 102: 1126-1131
        • Holland R.
        • Battersby J.
        • Harvey I.
        • Lenaghan E.
        • Smith J.
        • Hay L.
        Systematic review of multidisciplinary interventions in heart failure.
        Heart. 2005; 91: 899-906
        • Belardinelli R.
        • Georgiou D.
        • Cianci G.
        • Purcaro A.
        Randomized, controlled trial of long-term moderate exercise training in chronic heart failure effects on functional capacity, quality of life, and clinical outcome.
        Circulation. 1999; 99: 1173-1182
        • Khunti K.
        • Hearnshaw H.
        • Baker R.
        • Grimshaw G.
        Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners.
        Eur J Heart Fail. 2002; 4: 771-777
        • O'Connor C.M.
        • Whellan D.J.
        • Lee K.L.
        • Keteyian S.J.
        • Cooper L.S.
        • Ellis S.J.
        • Leifer E.S.
        • Kraus W.E.
        • Kitzman D.W.
        • Blumenthal J.A.
        • Rendall D.S.
        Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
        JAMA. 2009; 301: 1439-1450
        • Papadakis S.
        • Oldridge N.B.
        • Coyle D.
        • Mayhew A.
        • Reid R.D.
        • Beaton L.
        • Dafoe W.A.
        • Angus D.
        Economic evaluation of cardiac rehabilitation: a systematic review.
        Eur J Cardiovasc Prev Rehabil. 2005; 12: 513-520
        • Kühr E.M.
        • Ribeiro R.A.
        • Rohde L.E.P.
        • Polanczyk C.A.
        Cost-effectiveness of supervised exercise therapy in heart failure patients.
        Value Health. 2011; 14: S100-S107
        • Bakal J.A.
        • McAlister F.A.
        • Liu W.
        • Ezekowitz J.A.
        Heart failure re-admission: measuring the ever shortening gap between repeat heart failure hospitalizations.
        PLoS ONE. 2014; 9 (e106494)
        • Adams K.F.
        • Fonarow G.C.
        • Emerman C.L.
        • LeJemtel T.H.
        • Costanzo M.R.
        • Abraham W.T.
        • Berkowitz R.L.
        • Galvao M.
        • Horton D.P.
        • ADHERE Scientific Advisory Committee and Investigators
        Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).
        Am Heart J. 2005; 149: 209-216
        • Delea T.E.
        • Vera-Llonch M.
        • Richner R.E.
        • Fowler M.B.
        • Oster G.
        Cost effectiveness of carvedilol for heart failure.
        Am J Cardiol. 1999; 83: 890-896
        • Pocock S.J.
        • Wang D.
        • Pfeffer M.A.
        • Yusuf S.
        • McMurray J.J.
        • Swedberg K.B.
        • Östergren J.
        • Michelson E.L.
        • Pieper K.S.
        • Granger C.B.
        Predictors of mortality and morbidity in patients with chronic heart failure.
        Eur Heart J. 2006; 17: 65-75
        • Setoguchi S.
        • Stevenson L.W.
        • Schneeweiss S.
        Repeated hospitalizations predict mortality in the community population with heart failure.
        Am Heart J. 2007; 154: 260-266
        • McAlister F.A.
        • Stewart S.
        • Ferrua S.
        • McMurray J.J.
        Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials.
        J Am Coll Cardiol. 2004; 44: 810-819
        • Sagar V.A.
        • Davies E.J.
        • Briscoe S.
        • Coats A.J.
        • Dalal H.M.
        • Lough F.
        • Rees K.
        • Singh S.
        • Taylor R.S.
        Exercise-based rehabilitation for heart failure: systematic review and meta-analysis.
        Open Heart. 2015; 2: e000163
        • Smart N.
        • Marwick T.H.
        Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity.
        Am J Med. 2004; 116: 693-706
        • Chan D.C.
        • Heidenreich P.A.
        • Weinstein M.C.
        • Fonarow G.C.
        Heart failure disease management programs: a cost-effectiveness analysis.
        Am Heart J. 2008; 155: 332-338
        • Georgiou D.
        • Chen Y.
        • Appadoo S.
        • Belardinelli R.
        • Greene R.
        • Parides M.K.
        • Glied S.
        Cost-effectiveness analysis of long-term moderate exercise training in chronic heart failure.
        Am J Cardiol. 2001; 87: 984-988
        • Packer M.
        • Coats A.J.
        • Fowler M.B.
        • Katus H.A.
        • Krum H.
        • Mohacsi P.
        • Rouleau J.L.
        • Tendera M.
        • Castaigne A.
        Effect of carvedilol on survival in severe chronic heart failure.
        New Engl J Med. 2001; 344: 1651-1658
        • Chiang J.
        • Chib S.
        • Narasimhan C.
        Markov chain Monte Carlo and models of consideration set and parameter heterogeneity.
        J Econometrics. 1998; 89: 223-248
        • Baio G.
        • Dawid A.P.
        Probabilistic sensitivity analysis in health economics.
        Stat Methods Med Res. 2015; 24: 615-634
        • Sanders G.D.
        • Neumann P.J.
        • Basu A.
        • Brock D.W.
        • Feeny D.
        • Krahn M.
        • Kuntz K.M.
        • Meltzer D.O.
        • Owens D.K.
        • Prosser L.A.
        • Salomon J.A.
        Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine.
        JAMA. 2016; 136: 1093-1103
        • Grosse S.D.
        Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold.
        Expert Rev Pharmacoecon Outcomes Res. 2008; 8: 165-178
        • Neumann P.J.
        • Cohen J.T.
        • Weinstein M.C.
        Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold.
        New Engl J Med. 2014; 371: 796-797
        • Rich M.W.
        • Beckham V.
        • Wittenberg C.
        • Leven C.L.
        • Freedland K.E.
        • Carney R.M.
        A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure.
        New Engl J Med. 1995; 333: 1190-1195
        • Stewart S.
        • Marley J.E.
        • Horowitz J.D.
        Effects of a multidisciplinary, home-based intervention on planned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study.
        Lancet. 1999; 354: 1077-1083
        • Belardinelli R.
        • Georgiou D.
        • Cianci G.
        • Purcaro A.
        10-year exercise training in chronic heart failure: a randomized controlled trial.
        J Am Coll Cardiol. 2012; 60: 1521-1528
        • Nyman J.A.
        Should the consumption of survivors be included as a cost in cost-utility analysis?.
        Health Econ. 2004; 13: 417-427